Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Baird Medical Investment HoldingsBDMD -2.86%17 Receivables Turnover is 0.35 as of Dec. 2025. GuruFocus rates BDMD with a GF Score™ of 17/100. The stock has 7 warning signs investors should review. Among 812 Medical Devices & Instruments companies, Baird Medical Investment Holdings ranks worse than 98.4% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Baird Medical Investment Holdings's Revenue for the
six
months ended in Dec. 2025 was $14.58 Mil. Baird Medical Investment Holdings's average Accounts Receivable for the
six
months ended in Dec. 2025 was $41.68 Mil.
Hence, Baird Medical Investment Holdings's Receivables Turnover for the
six
months ended in Dec. 2025 was 0.35.
Baird Medical Investment Holdings (NAS:BDMD) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Baird Medical Investment Holdings Receivables Turnover Related Terms
Baird Medical Investment Holdings Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baird Medical Investment Holdings Receivables Turnover Chart
Baird Medical Investment Holdings Annual Data
Trend
Dec21
Dec22
Dec23
Dec24
Dec25
Receivables Turnover
2.48
1.97
1.13
0.95
0.51
Baird Medical Investment Holdings Semi-Annual Data
BDMD vs TELA, NSPR, PAVM: Receivables Turnover Comparison
For the Medical Devices subindustry, Baird Medical Investment Holdings's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baird Medical Investment Holdings Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Baird Medical Investment Holdings's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baird Medical Investment Holdings (BDMD) has a Receivables Turnover of 0.35 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Baird Medical Investment Holdings and its competitors. According to the industry distribution chart, Baird Medical Investment Holdings ranks #799 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 98.4%.
Is Baird Medical Investment Holdings' Receivables Turnover too high?
Baird Medical Investment Holdings' current Receivables Turnover is 0.35. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Baird Medical Investment Holdings' value of 0.35 is 93.6% below this industry median. Based on the distribution chart, Baird Medical Investment Holdings ranks #799 out of 812 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Baird Medical Investment Holdings has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Baird Medical Investment Holdings' Receivables Turnover compare to TELA and NSPR?
According to the Medical Devices & Instruments industry distribution chart, Baird Medical Investment Holdings ranks #799 out of 812 companies for Receivables Turnover. This places Baird Medical Investment Holdings in the lower half of its industry. The industry median Receivables Turnover is 5.51. Baird Medical Investment Holdings' value of 0.35 is 93.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baird Medical Investment Holdings's current Receivables Turnover of 0.35 is 93.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Baird Medical Investment Holdings and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baird Medical Investment Holdings's current Receivables Turnover is 0.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baird Medical Investment Holdings stock overvalued right now?
Baird Medical Investment Holdings (BDMD) has a current Receivables Turnover of 0.35. The current Receivables Turnover is 0.35 and 93.6% below the Medical Devices & Instruments industry median of 5.51. Baird Medical Investment Holdings' overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Baird Medical Investment Holdings (BDMD), the current Receivables Turnover is 0.35 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Baird Medical Investment Holdings Business Description
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
17GF Score
Get the complete analysis for BDMD
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDMD has been successfully added to your 
